Recurrent Gastric Cancer Terminated Phase Trials for Motexafin lutetium (DB05296)

Also known as: Gastric cancer recurrent / Stomach cancer recurrent / Stomach carcinoma recurrent / Gastric carcinoma recurrent

IndicationStatusPhase
DBCOND0028800 (Recurrent Gastric Cancer)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00087191EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerDiagnostic